European Commission Grants Another Year of Conditional Approval to PTC Therapeutics' (PTCT) Translarna in Nonsense Mutation Duchenne Muscular Dystrophy

Source Link:

http://www.prnewswire.com/news-releases/european-commission-ratifies-positive-chmp-opinion-for-the-renewal-of-translarna-marketing-authorization-for-the-treatment-of-nonsense-mutation-duchenne-muscular-dystrophy-300388180.html